# Nicolas SÉRÈS

> Nicolas SÉRÈS is a seed investor at WiSEED (Toulouse) backing Life Science and Biotechnology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [WiSEED](https://shizune.co/investors/profile/wiseed)
- Location: Toulouse, France
- Total investments: 1
- Last investment: Oct 2012
- Lead investor: 100%
- Last updated: Aug 2026

Nicolas SÉRÈS is a seed investor at WiSEED in Toulouse focused on Life Science and Biotechnology. Nicolas SÉRÈS - Co-Founder & CEO @ WiSEED

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Life Science | 1 | 100% |
| Biotechnology | 1 | 100% |
| Medical Device | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Antabio | Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need. It develops stand-alone inhibitors of bacterial metalloenzymes that can be combined with various antibiotics to restore their activity against the most critical pathogens. Thecompany's novel inhibitor of bacterial Metallo ß-lactamases (“MBLs”) which will be combined with a carbapenem to fill an important gap in the treatment of drug-resistant infections. They develop a novel, safe and efficacious inhibitor of bacterial Metallo ß-lactamases to be combined with a carbapenem for the treatment of drug-resistant nosocomial infections.Antabio received a Wellcome Trust Seeding Drug Discovery Award. The company was founded in 2009 and is headquartered in Labege, France. |  | Seed | Oct 01, 2012 |  |

1 of 1 investments shown.

## About WiSEED

VC Fund · Toulouse, France

Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.

3 contacts available at WiSEED.

| Name | Title | Profile |
| --- | --- | --- |
| Nicolas SÉRÈS | Co-Founder & CEO | https://shizune.co/investors/profile/nicolas-s%C3%89r%C3%88s |
| Stephanie SAVEL | President | https://shizune.co/investors/profile/stephanie-savel |
| Thierry MERQUIOL | Co-Founder & Chairman of the board | https://shizune.co/investors/profile/thierry-merquiol |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Nicolas SÉRÈS invest in?

Nicolas SÉRÈS invests primarily in Life Science, Biotechnology and Medical Device startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Nicolas SÉRÈS last invest?

The most recent investment recorded for Nicolas SÉRÈS closed in Oct 2012. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co